Start-up Zone

Preterm infant in the neonatal unit

Neonatal therapeutics company raises $35 million

22 December 2022

Tellus Therapeutics, a company developing treatments for newborns in the neonatal intensive care unit (NICU), announced the closing of a Series A financing round of $35 million led by the Perceptive Xontogeny Venture Fund.   The capital will be used to continue preclinical work conducted through the seed investment with the Xontogeny development team and to […]

Protein

Therapeutic protein project joins Bio Studio programme

20 December 2022

A project creating a new class of therapeutic proteins to modulate cell signalling has been accepted into the BioInnovation Institute (BII) Bio Studio programme. The project is based on recent breakthroughs in artificial intelligence (AI) and protein design, and uses methods pioneered by David Baker’s laboratory at the University of Washington’s Institute for Protein Design. […]

Human antibodies

Start-up focusses on human-derived antibody drugs

7 December 2022

Biotechnology company Infinimmune has closed a $12 million seed round to focus on human-derived antibody drugs. The seed funding was led by Playground Global, with participation from Pear VC, Civilization Ventures, Axial VC, Ron Alfa, Jacob Becraft, Paul Conley, and Joshua Meier. “The industry has proven the value of antibody-based drugs, but the limited number […]

Pedro Correa de Sampaio and Annelise Soulier

Start-up raises £520K to improve immunotherapy outcomes

28 November 2022

Neobe Therapeutics, an early-stage startup, has raised £520K ($628,000) in equity funding to engineer live biotherapeutics to remove barriers to immune infiltration in solid tumours.  While immunotherapies have revolutionised the treatment of cancer, the large majority of patients with solid tumours (up to 85%) still do not respond to them. Neobe was founded by Pedro […]

""

New biotech aspires to reveal insights into disease biology

18 November 2022

A new biotechnology company plans to pioneer the integrated mapping of disease networks for precision therapeutics. Rezo Therapeutics has launched with $78 million from a Series A financing, led by SR One, a16z Bio + Health, and Norwest Venture Partners. The company’s platform is based on technology from the Quantitative Biosciences Institute (QBI) at the […]

Tomi Kalpio

A personal touch: the role of bioprinting in drug discovery

5 October 2022

DDW Editor, Reece Armstrong, sits down with Brinter CEO Tomi Kalpio to learn about the company’s approach to bioprinting and how it can be used throughout drug discovery.  Brinter is a provider of 3D bioprinting solutions based in Turku, Finland and the US. The company has developed modular technology that can print multi-material and highly […]

Start-up raises £1.3M to ‘revolutionise’ infant gut health

16 September 2022

A female-led start-up developing a live biotherapeutic product to address infant gut needs, has raised £1.3M ($1.5M) in equity and grant funding.  BoobyBiome, founded by scientists Dr Lydia Mapstone, Dr Sioned Jones and Tara O’Driscoll, aims to develop a novel product for babies who do not have access to the microbiome in breast milk.  Working […]

Medical researchers

More start-ups join Venture Lab programme

6 September 2022

The latest cohort of companies have joined the Venture Lab acceleration programme for early-stage companies, created by non-profit foundation the BioInnovation Institute (BII). Designed to help build research-based ideas with high-growth commercial potential into viable start-ups, BII’s 12-month Venture Lab programme supports business acceleration, scientific and team development. It provides a risk-free convertible loan of […]

Global pharma start-up success stories

7 July 2022

From AI to 3D deep-learning research to biologics, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery. Owkin French-American startup, Owkin is focussed on using artificial intelligence (AI) to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. Using AI, the company identifies new drug […]

Spotlight: Tackling the issue of scientific data waste 

28 February 2022

More than half of all scientific research is irreproducible, and more than 80% of scientific research data is being lost within 20 years. In the biomedical field alone, irreproducible research costs the industry £28 billion (US$38 billion) every year. Megan Thomas talks to Founder of Labstep Jake Schofield, about this issue.  MT: Huge amounts of scientific data […]

« Previous
Next »